ChloraSolv is regulatory approved for diabetic foot ulcers in New Zealand
RLS Global has received regulatory approval for ChloraSolv for treatment of diabetic foot ulcers in New Zealand. With this approval, RLS has established a first market presence in Oceania. The next step will be to broaden the indication in this market."RLS has a strategic regulatory plan which aims to give as many patients as possible the opportunity to be treated with ChloraSolv. New Zeeland is a small market, but the fact that the authorities have approved ChloraSolv indicated the patient benefit with the product and its mechanism of action", says Karin Fischer, CEO of RLS Global. "